Eriko Kudo Selected Research

Vasculitis (Vasculitides)

1/2006

Minocycline-induced vasculitis fulfilling the criteria of polyarteritis nodosa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eriko Kudo Research Topics

Disease

6	Infections 04/2020 - 02/2013
4	Neoplasms (Cancer) 10/2016 - 04/2012
3	Primary Effusion Lymphoma 10/2016 - 04/2012
2	Human Influenza (Influenza) 04/2020 - 01/2019
2	Hypoxia (Hypoxemia) 07/2016 - 01/2016
2	Cholangiocarcinoma 07/2016 - 01/2013
2	Ascites 03/2015 - 04/2012
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2023
1	Gliosis 10/2022
1	Ataxia (Dyssynergia) 10/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 01/2020
1	Cachexia 05/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Liver Neoplasms (Liver Cancer) 07/2016
1	Neoplasm Metastasis (Metastasis) 01/2013
1	Retinoblastoma (Glioblastoma, Retinal) 04/2012
1	Vasculitis (Vasculitides) 01/2006
1	Fever (Fevers) 01/2006
1	Polyneuropathies (Polyneuropathy) 01/2006
1	Polyarteritis Nodosa (Periarteritis Nodosa) 01/2006
1	Pain (Aches) 01/2006
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 07/2005
1	Eosinophilia 07/2005

Drug/Important Bio-Agent (IBA)

3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2016 - 03/2015
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2019
2	Bevacizumab (Avastin)FDA Link 07/2016 - 03/2015
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 03/2015
2	GUT-70IBA 02/2015 - 02/2013
1	CalciumIBA 10/2022
1	Reverse Transcriptase InhibitorsIBA 10/2022
1	ElementsIBA 10/2022
1	NucleosidesIBA 10/2022
1	DNA Transposable Elements (Element, IS)IBA 10/2022
1	AerosolsIBA 04/2020
1	Aerosolized Particles and DropletsIBA 04/2020
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2020
1	Sodium-Glucose Transport ProteinsIBA 01/2020
1	CarbohydratesIBA 11/2019
1	KetonesIBA 11/2019
1	Indicators and Reagents (Reagents)IBA 05/2019
1	CaspasesIBA 01/2019
1	Chloroquine (Aralen)FDA LinkGeneric 10/2016
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 07/2016
1	Small Interfering RNA (siRNA)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Oxygen (Dioxygen)IBA 01/2016
1	tocilizumab (atlizumab)FDA Link 03/2015
1	Interleukin-6 (Interleukin 6)IBA 03/2015
1	NF-kappa B (NF-kB)IBA 01/2013
1	Ditiocarb (Sodium Diethyldithiocarbamate)FDA Link 01/2013
1	BerberineIBA 04/2012
1	Poly IIBA 04/2012
1	Double-Stranded RNA (RNA, Double Stranded)IBA 04/2012
1	Retinoblastoma ProteinIBA 04/2012
1	Toll-Like Receptor 3IBA 04/2012
1	Minocycline (Cyclops)FDA LinkGeneric 01/2006
1	C-Reactive ProteinIBA 01/2006
1	Immunoglobulin E (IgE)IBA 07/2005
1	Immunoglobulin G (IgG)IBA 07/2005
1	Interleukin-4 (Interleukin 4)IBA 07/2005
1	Interleukin-5 (Interleukin 5)IBA 07/2005

Therapy/Procedure

1	Glycemic Control 01/2020
1	Ketogenic Diet 11/2019
1	Therapeutics 11/2019
1	Diagnostic Equipment 05/2019
1	Drug Therapy (Chemotherapy) 10/2016